Clot-Busting Stroke Drug Could Save $200M Annually



Treating mild strokes with an intravenous tissue plasminogen activator (tPA), a drug usually reserved for more severe strokes, could save costs by reducing the disabling after-effects of a stroke, researchers say.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.